Ispire-Backed IKE Tech to Present 7th Annual Next Generation Nicotine Delivery USA Conference

Rhea-AI Summary

Ispire Technology (NASDAQ: ISPR) announced that IKE Tech, its joint venture, will present at the 7th Annual Next Generation Nicotine Delivery USA Conference in Miami. The presentation follows IKE Tech's groundbreaking PMTA filing with the FDA for a Bluetooth Low Energy System-on-a-Chip featuring blockchain-enabled age verification for ENDS devices. This marks the first complete PMTA submission for a universal, interoperable age-verification component. John Patterson, SVP of International Nicotine at Ispire and IKE Tech president, will discuss youth vaping challenges and their technology solution at a panel on June 4. The system implements continuous, real-time identity verification, going beyond traditional point-of-purchase age checks. IKE Tech has received an Acceptance Review letter from the FDA and requested expedited review citing public health benefits.

Conference Attendance Follows Groundbreaking FDA PMTA Filing for Blockchain-Powered Age-Gating System

LOS ANGELES, June 3, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that IKE Tech LLC ("IKE Tech"), a joint venture that includes Ispire as a founding partner, will showcase their technology at the 7th Annual Next Generation Nicotine Delivery USA at the Hyatt Regency in Miami from June 4-5th. This event convenes key business leaders from the FDA, the ENDS (Electronic Nicotine Delivery Systems) sector, and the tobacco industry across the U.S. market to explore strategies for legal compliance and commercial success.

The announcement comes on the heels of IKE Tech's historic milestone, in which the joint venture filed a component Pre-Market Tobacco Product Application (PMTA) and Tobacco Product Master File (TPMF) with the U.S. Food and Drug Administration (FDA) for its Bluetooth Low Energy (BLE) System-on-a-Chip. IKE Tech has now received an Acceptance Review letter from the FDA, confirming that their PMTA meets regulatory requirements to be accepted, and moves the application into the FDA's filing review phase.

This marked the first-ever complete PMTA submission for a standalone, interoperable, blockchain-enabled age-verification component designed for universal integration across all ENDS devices. Unlike traditional systems that verify age only at the point of purchase, IKE Tech's platform requires continuous, real-time identity verification, offering an unprecedented level of security against underage vaping. IKE has formally requested expedited review of the application, citing its potential to significantly enhance public health.

At the conference, John Patterson, senior vice president of International Nicotine at Ispire and president of IKE Tech, will speak on a panel titled "Technology to End Youth Vaping for Electronic Nicotine Delivery Systems," scheduled for Wednesday, June 4, at 2:00 p.m. In his capacity as President of IKE Tech, Patterson will discuss:

• The persistent challenge of youth vaping in the U.S.
• Gaps in existing regulatory approaches and their unintended consequences for adult users
• Continuous age verification at the point of use as a direct solution to youth access
• Leveraging cutting-edge technologies—including biometric verification, blockchain security, and BLE—to set new industry standards and ensure ENDS access is restricted to authorized adults

To schedule a meeting with John Patterson or other Ispire representatives, please email john.p@iketech.com.

About IKE Tech LLC
IKE Tech LLC is a joint venture comprised of three leading technology and research companies -- Ispire Technology Inc, Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. -- dedicated to revolutionizing Identity and Age Verification (IAV) technology solutions. Recognizing the absence of a universal point-of-sale IAV solution and recognition of the need for one, these companies joined forces to create a unique IAV technology component. IKE's mission is to set the gold standard for IAV by (i) permitting access to electronic nicotine delivery systems by authorized adult users while (ii) preventing underage access through a "plug and play" component compatible across different devices and platforms.

About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Twitter and YouTube.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success of meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

IR Contacts:
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com

KCSA Strategic Communications
Phil Carlson
212.896.1233
ispire@kcsa.com

PR Contact:
Ellen Mellody
570.209.2947
ispire@kcsa.com

View original content:https://www.prnewswire.com/news-releases/ispire-backed-ike-tech-to-present-7th-annual-next-generation-nicotine-delivery-usa-conference-302471208.html

SOURCE Ispire Technology Inc.

FAQ

What is IKE Tech's new age verification technology for vaping devices?

IKE Tech developed a Bluetooth Low Energy System-on-a-Chip with blockchain-enabled continuous age verification that requires real-time identity verification for ENDS devices, going beyond traditional point-of-purchase checks.

What is the status of IKE Tech's FDA PMTA application for their age verification system?

IKE Tech has received an Acceptance Review letter from the FDA confirming their PMTA meets regulatory requirements, and the application has moved into the filing review phase with a request for expedited review.

When and where will Ispire's IKE Tech present their technology?

IKE Tech will present at the 7th Annual Next Generation Nicotine Delivery USA Conference at the Hyatt Regency in Miami from June 4-5th, 2025.

Who will represent IKE Tech at the Nicotine Delivery Conference?

John Patterson, senior vice president of International Nicotine at Ispire and president of IKE Tech, will speak on a panel titled 'Technology to End Youth Vaping for Electronic Nicotine Delivery Systems' on June 4 at 2:00 p.m.